References
Adamson MD, Andersson HC, Gahl WA (1989) Cystinosis.Semin Nephrol 9: 147–161.
Barth PG, Scholte HR, Berden JA et al (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leukocytes.J Neurol Sci 62: 327–365.
Gahl WA, Reed GF, Thoene JG et al (1987) Cysteamine therapy for children with nephropathic cystinosis.N Engl J Med 316: 971–977.
Gahl WA, Schneider JA, Schulman JD, Thoene JG, Reed GF (1990) Predicted reciprocal serum creatinine at age 10 years as a measure of renal function in children with nephropathic cystinosis treated with oral cysteamine.Pediatr Nephrol 4: 129–135.
Gahl WA, Charnas L, Markello TC et al (1992) Parenchymal organ cystine depletion with long-term cysteamine therapy.Biochem Med Metab Biol 48: 275–285.
Gahl WA, Bernardini I, Dalakas M et al (1993) Muscle carnitine repletion by long-term carnitine supplementation in nephropathic cystinosis.Pediatr Res 34: 115–119.
Markello TC, Bernardini IM, Gahl WA (1993) Improved renal function in children with cystinosis treated with cysteamine.N Engl J Med 328: 1157–1162.
Reznik VM, Adamson M, Adelman RD et al (1991) Treatment of cystinosis with cysteamine from early infancy.J Pediatr 119: 491–494.
Schneider JA, Katz B, Melles RB (1990) Update in nephropathic cystinosis.Pediatr Nephrol 4: 645–653.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vilaseca, M.A., Camacho, J.A., Briones, P. et al. Biochemical follow-up in late-treated nephropathic cystinosis. J Inherit Metab Dis 18, 147–150 (1995). https://doi.org/10.1007/BF00711751
Issue Date:
DOI: https://doi.org/10.1007/BF00711751